Member Info for market22

Top fund mangers building slowly as not to disturb. we all need to make decisions based on research

You may miss the boat, this company is a hot takeover target that's were your value lies as per bloomberg and your own chairman.

this is f an tas ic news good nihkt

Burford capital went i at 3.50 purple bricks went in at 2.10 great results without much effort. Tissue Reginex at 15p is my next hit. Not me Woodford. Good luck

Been invested here from 12p nice profit, just waiting for the opportunity to build, do your research.

Edison well respected and have a accurate track record have under valued at 44.4 a share, simply because so few shares are available, Won,t sell as takeover possibilities/ or further developments reduce the risk to the upside.

As most already know Woodford sold tissue and Abzena to fund a average down on the Northwest Bio, and a legal challenge. Only he knows why he cut is stake to 14%, hence the share price fall and the spread. Anyway away Woodford Tissue is growing in strength just be patient this will deliver.

Are you still around, I remember you being a long term holder a couple of years back. Hope you stayed in and starting to enjoy the recent news and exciting prospects and of course the nice price movement.

Woodford built up the stake Invesco Perpetual hold when he was managing that fund, and they still hold a substantial holding. He came in at the start. On starting CF Woodford Tissue was one of the first shares he purchased in his new fund.This is a good story albeit its taking a little longer than first expected. In 2014 the Chairman stated he expected Tissue to become a takeover target as the products roll out. I have been here since 2012 holding at 10.5pence have seen 30p but expect we will surpass that in the not to distant future.

Its unlikely the Hardman report will have much influence, the 800k a month burn is what the company has forecast. What we need is sales to cut that burn figure this year, any drop in burn should be market positive. The first million in sales as per RNS is surely ahead of schedule. So in my view steady as she goes and with patience our rewards could be in line with the my expectations

Another piece falls nicely into play, this really does appear to be a very good story unfolding.

Revenue coming through to what would be until the end of June as there is about a thirty day turn around with most medi care companies. the next six months revenue will tell much more than today. Its only just got going and surely some suitors are watching this space..

One can only hope prior to results the MM are pushing it down to buy lower, this is my hunch as we must be generating new income the question is how much ?

That is why its off most peoples radar, but not Neil Woodford's or mine. Unique technology also being tested in the manufacturing industry. Hard to see this technology not being used worldwide.

With only one third of the shares in public hands, and no major share holders unloading its difficult to put the recent volatility into any perspective, I have spent many hours today researching Tissue and cannot come up with anything. Any one else got any info?.

Can not find any shorts to mention, but something is afoot.

The spread suggests there is not a major increase in activity around the share price, but again increasing the sales force would suggest the current reps are working at full capacity, and just maybe this is the start of a move forward during the coming months.

I agree I will try your suggestion, thanks for the great informative posts on the Centamin board.

This market cannot be manipulated like the aim, investors are to smart, But market makers will try to move the price down using shorts, UT trades, 7.50AM Auctions. Hold tight I am through research sure these will be big numbers on new business and funds under management. Many new partners, with little serious competition from the fee based based sector. Top quality wealth management from very qualified advisers. Lets look forward to this posh company delivering to investors golden flip flops

The recent retail distribution review (RDR) will have been extremely helpful to St James's place with recruiting top quality advisers, I think this will have resulted in a steep increase in adviser numbers that will translate into very powerful new business figures on the 22nd. I suspect numbers will beat expectations.